Orlistat Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Orlistat Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22916
Buy Now

Orlistat Prices June 2023

Product
Category Region Price
Orlistat Pharma API USA 389743 USD/MT (Jun, 23)
Orlistat Pharma API China 376819 USD/MT (Jun, 23)
Orlistat Pharma API Germany 385196 USD/MT (Jun, 23)


The price of orlistat in the United States for Q2 2023 reached 389743 USD/MT in June. Similarly, the price of orlistat in China for Q2 2023 reached 376819 USD/MT. Moreover, in Germany, the price of orlistat for Q2 2023 reached 385196 USD/MT.

Orlistat Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Orlistat Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of orlistat pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of orlistat at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of orlistat price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing orlistat price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Orlistat Price Trend

Orlistat Market Analysis

The global orlistat market size reached US$ 3.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 5.9 Billion, at a projected CAGR of 6.20% during 2023-2032.

  • Obesity rates have seen a dramatic increase globally, significantly influencing the orlistat market. According to the World Health Organization (WHO), as of 2022, 1 in 8 people worldwide were living with obesity, with adult obesity rates more than doubling since 1990 and quadrupling among children and adolescents aged 5 to 19 years. Specifically, 2.5 billion adults were overweight, and 890 million of these were classified as obese. This rapid rise in obesity has heightened public awareness of its associated health risks, including cardiovascular diseases, type 2 diabetes, and various cancers. This increased awareness is driving demand for effective weight management solutions like orlistat, which is known to help reduce the absorption of dietary fats.
  • Government initiatives aimed at managing obesity are crucial drivers of the orlistat market. The World Health Organization (WHO) has been a leading force in this regard, implementing the WHO Acceleration Plan to Stop Obesity. This plan, endorsed by the 75th World Health Assembly in 2022, is designed to stimulate and support multi-sectoral action at the country level. It emphasizes scaling up proven policies and strategies to tackle the obesity epidemic globally. As of 2023, 31 governments have adopted the plan, implementing core interventions such as promoting breastfeeding, regulating food marketing to children, and integrating obesity prevention into primary health care systems.
  • The shift of orlistat from a prescription-only medication to an over the counter (OTC) product in many regions has significantly expanded its market reach. This change allows individuals to access orlistat more conveniently, increasing its popularity as a weight loss aid. Pharmacies, including online platforms, have capitalized on this trend by promoting OTC orlistat products extensively. Marketing campaigns targeting weight-conscious consumers have heightened the visibility and appeal of these products. The easier accessibility and broader consumer base are key factors driving the growth of the OTC orlistat market, making it a more attractive option for those seeking immediate weight loss solutions​. According to the Consumer Healthcare Products Association, approximately 81% of adults in the U.S. use OTC medicines as a first response to minor ailments, highlighting the preference for accessible and convenient healthcare options without needing a prescription​.

Orlistat News

The report covers the latest developments, updates, and trends impacting the global orlistat market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in orlistat production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the orlistat price trend.

Latest developments in the orlistat industry:

  • On May 18, 2023, Teva Pharmaceutical Industries Ltd., announced a new strategic framework with four main pillars to position the company for a new era of growth. This strategy aims to bolster the company’s strong commercial portfolio with AUSTEDO, AJOVY, UZEDYTM, and biosimilars, to amplify its innovative pipeline, sustain its generics powerhouse, and focus on the business. These four pillars are expected to deliver enhanced value and create a greater impact for patients.

Product Description

One diet drug, orlistat, is now approved to treat obesity. It works in your intestines to block the absorption of fats from the foods you eat—by acting in a much different way than the other medicines. When used in conjunction with a low-calorie diet and exercise, it's supposed to help minimize the amount of fatty food a person consumes, which can decrease body weight. Xenical, which is the prescription form, is advised for those people with overweight who also have other risk factors including, orlistat works by inhibiting pancreatic lipase, an enzyme needed by the small intestines to break down the triglycerides. Action of the lipase is inhibited, meaning the triglycerides are undigested, which otherwise would have been absorbed as free fatty acids, hence leading to decreased calorie intake and reduced absorption of fat. Clinical investigations have shown that orlistat can significantly reduce weight and improve cardiovascular risk factors when used in addition to a complete weight control program. The most common side effects are gastrointestinal problems, such as bloating and greasy stools.

Regional Coverage

The report provides a detailed analysis of the orlistat market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the orlistat price trend.

Global Orlistat Price

The report offers a holistic view of the global orlistat pricing trends in the form of orlistat price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of orlistat but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed orlistat demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Orlistat Price

European orlistat prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed orlistat price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Orlistat Price

The analysis of orlistat prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific orlistat historical data within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Orlistat Price

The report explores the orlistat pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on orlistat prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Orlistat Price

The orlistat pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This orlistat price analysis can be expanded to include a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Orlistat Price

The analysis of orlistat prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Orlistat
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Orlistat Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of orlistat pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting orlistat price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The orlistat price charts ensure our clients remain at the forefront of the industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Orlistat Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More